Effect of dandelion capsule on non-alcoholic fatty liver disease

Phase 2

Recruiting

• Conditions: Fatty (change of) liver, not elsewhere classified; Condition 1: Nonalcoholic steatohepatitis. Condition 2: Fatty liver.; Nonalcoholic steatohepatitis (NASH); K75.81

• Registration Number: IRCT20161205031252N10
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Grade 2 and 3 of Non-alcoholic fatty liver
Hemoglobin above 13 in male and above 12 in female

Exclusion Criteria

History of allergy to plants of asteraceae
Bile duct or intestinal obstruction
Diabetes and renal failure
Pregnant and lactating women
Weight below 50 kg
Consumers of lithium, tetracyclines, fluoroquinolones, blood glucose lowering drugs and blood thinners drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver stiffness. Timepoint: Three months after treatment. Method of measurement: Fibroscan.

Secondary Outcome Measures

Name	Time	Method
Blood levels of liver enzymes. Timepoint: Three months after treatment. Method of measurement: Blood test.